INCB024360 (Epacadostat) monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: primary results from first-in-Japanese phase I study (KEYNOTE-434)

被引：4
|
作者：
Fujiwara, Yutaka [1 ]
Shitara, Kohei [2 ]
Shimizu, Toshio [1 ]
Yonemori, Kan [1 ]
Matsubara, Nobuaki [2 ]
Ohno, Izumi [2 ]
Kogawa, Takahiro [2 ]
Naito, Yoichi [2 ]
Leopold, Lance [3 ]
Sasahara, Kahori [4 ]
Yatsuzuka, Naoyoshi [4 ]
Takami, Tomoko [4 ]
Shimamoto, Takashi [4 ]
Yamamoto, Noboru [1 ]
Doi, Toshihiko [2 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Incyte Corp, Wilmington, DE USA
[4] MSD KK, Tokyo, Japan
来源：
MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期
关键词：
D O I：
10.1158/1535-7163.TARG-17-A204
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A204
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Pharmacokinetics and safety of olaparib tablets as monotherapy and in combination with paclitaxel: results of a Phase I study in Chinese patients with advanced solid tumours
    Yuan, Peng
    Shentu, Jianzhong
    Xu, Jianming
    Burke, Wendy
    Hsu, Kate
    Learoyd, Maria
    Zhu, Min
    Xu, Binghe
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (05) : 963 - 974
  • [42] Pharmacokinetics and safety of olaparib tablets as monotherapy and in combination with paclitaxel: results of a Phase I study in Chinese patients with advanced solid tumours
    Peng Yuan
    Jianzhong Shentu
    Jianming Xu
    Wendy Burke
    Kate Hsu
    Maria Learoyd
    Min Zhu
    Binghe Xu
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 963 - 974
  • [43] A phase 1/1b first-in-human (FIH) study of JZP898 as monotherapy and in combination with pembrolizumab in adult patients with advanced or metastatic solid tumors.
    McKean, Meredith
    Hutson, Thomas E.
    Piha-Paul, Sarina A.
    Micaily, Ida
    Liao, Mingxiang
    Humphreys, Robin
    Brock, Graham
    Sahr, Natasha
    Amber, Vian
    Spira, Alexander I.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] A Multicenter Phase I Study of Pazopanib in Combination with Paclitaxel in First-Line Treatment of Patients with Advanced Solid Tumors
    Kendra, Kari L.
    Plummer, Ruth
    Salgia, Ravi
    O'Brien, Mary E. R.
    Paul, Elaine M.
    Suttle, A. Benjamin
    Compton, Natalie
    Xu, Chun-Fang
    Ottesen, Lone H.
    Villalona-Calero, Miguel A.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (02) : 461 - 469
  • [45] First-in-human study of SRF388, a first-in-class IL-27 targeting antibody, as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors
    Naing, Aung
    Mantia, Charlene
    Morgensztern, Daniel
    Kim, Tae-Yong
    Li, Daneng
    Kang, Yoon-Koo
    Marron, Thomas Urban
    Tripathi, Abhishek
    George, Saby
    Rini, Brian I.
    El-Khoueiry, Anthony B.
    Vaishampayan, Ulka N.
    Kelley, Robin Kate
    Ornstein, Moshe Chaim
    Appleman, Leonard Joseph
    Harshman, Lauren C.
    Lee, Benjamin
    Tannir, Nizar M.
    Hammers, Hans J.
    Patnaik, Amita
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [46] Preliminary results of a phase I study of bevacizumab (BV) in combination with everolimus (E) in patients with advanced solid tumors.
    Zafar, Y.
    Bendell, J.
    Lager, J.
    Yu, D.
    George, D.
    Nixon, A.
    Petros, W.
    Beci, R.
    Arrowood, C.
    Hurwitz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 145S - 145S
  • [47] Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I study
    Xu, Jian Ming
    Wang, Yan
    Chen, Yu Ling
    Jia, Ru
    Li, Jie
    Gong, Ji Fang
    Li, Jing
    Qi, Chuan
    Hua, Ye
    Tan, Cui Rong
    Wang, Jian
    Li, Ke
    Sai, Yang
    Zhou, Feng
    Ren, Yong Xin
    Qing, Wei Guo
    Jia, Hong
    Su, Wei Guo
    Shen, Lin
    ONCOTARGET, 2017, 8 (26) : 42076 - 42086
  • [48] A phase I study of NC-6004, a micellar formulation of cisplatin, in combination with gemcitabine in Japanese patients with advanced solid tumors
    Hamaguchi, Tetsuya
    Doi, Toshihiko
    Shitara, Kohei
    Iwasa, Satoru
    Shimada, Yasuhiro
    Harda, Mitsunori
    Naito, Kenichiro
    Hayashi, Naoto
    Masada, Atsuhiro
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors
    Akiyoshi Kasuga
    Kazuhiko Nakagawa
    Fumio Nagashima
    Toshio Shimizu
    Daisuke Naruge
    Shinichi Nishina
    Hiroshi Kitamura
    Takayasu Kurata
    Atsuko Takasu
    Yasuhito Fujisaka
    Wataru Okamoto
    Yuichiro Nishimura
    Akihira Mukaiyama
    Hideki Matsushita
    Junji Furuse
    Investigational New Drugs, 2015, 33 : 1058 - 1067
  • [50] Phase I study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors
    Yamamoto, Noboru
    Koyama, Takafumi
    Sato, Jun
    Yoshida, Tatsuya
    Sudo, Kazuki
    Iwasa, Satoru
    Kondo, Shunsuke
    Yonemori, Kan
    Kawasaki, Atsuko
    Satake, Kyoko
    Shibata, Shoyo
    Shimizu, Toshio
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (01) : 109 - 115
12345